52 related articles for article (PubMed ID: 32321104)
21. [Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital].
Silva PR; Rabelo RA; Terra AP; Teixeira DN
Rev Soc Bras Med Trop; 2008; 41(2):158-62. PubMed ID: 18545836
[TBL] [Abstract][Full Text] [Related]
22. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro.
Franzot SP; Casadevall A
Antimicrob Agents Chemother; 1997 Feb; 41(2):331-6. PubMed ID: 9021188
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
Nooney L; Matthews RC; Burnie JP
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
[TBL] [Abstract][Full Text] [Related]
24. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans.
Hai TP; Van AD; Ngan NTT; Nhat LTH; Lan NPH; Vinh Chau NV; Thwaites GE; Krysan D; Day JN
Mycoses; 2019 Sep; 62(9):818-825. PubMed ID: 31173410
[TBL] [Abstract][Full Text] [Related]
25. Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.
Scorzoni L; de Paula E Silva AC; Marcos CM; Assato PA; de Melo WC; de Oliveira HC; Costa-Orlandi CB; Mendes-Giannini MJ; Fusco-Almeida AM
Front Microbiol; 2017; 8():36. PubMed ID: 28167935
[TBL] [Abstract][Full Text] [Related]
26. Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening.
Park YD; Sun W; Salas A; Antia A; Carvajal C; Wang A; Xu X; Meng Z; Zhou M; Tawa GJ; Dehdashti J; Zheng W; Henderson CM; Zelazny AM; Williamson PR
mBio; 2016 Aug; 7(4):. PubMed ID: 27486194
[TBL] [Abstract][Full Text] [Related]
27. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin.
Cogliati M; D'Amicis R; Zani A; Montagna MT; Caggiano G; De Giglio O; Balbino S; De Donno A; Serio F; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Oliveri S; Trovato L; Dipineto L; Rickerts V; McCormick-Smith I; Akcaglar S; Tore O; Mlinaric-Missoni E; Bertout S; Mallié M; Martins Mda L; Vencà AC; Vieira ML; Sampaio AC; Pereira C; Criseo G; Romeo O; Ranque S; Al-Yasiri MH; Kaya M; Cerikcioglu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Korem M; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Theelen B; Boekhout T; Lockhart SR; Tintelnot K; Tortorano AM; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Alonso B; Colom MF
FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27188887
[TBL] [Abstract][Full Text] [Related]
28. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species.
Brilhante RS; Caetano EP; Oliveira JS; Castelo-Branco Dde S; Souza ER; Alencar LP; Cordeiro Rde A; Bandeira Tde J; Sidrim JJ; Rocha MF
Braz J Infect Dis; 2015; 19(5):459-65. PubMed ID: 26119850
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.
Tewari A; Behera B; Mathur P; Xess I
Mycopathologia; 2012 Jun; 173(5-6):427-33. PubMed ID: 22354778
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.
Ferreira-Paim K; Andrade-Silva L; Mora DJ; Lages-Silva E; Pedrosa AL; da Silva PR; Andrade AA; Silva-Vergara ML
Mycopathologia; 2012 Jul; 174(1):41-52. PubMed ID: 22116628
[TBL] [Abstract][Full Text] [Related]
31. Primary cutaneous cryptococcosis caused by Cryptococcus gattii in an immunocompetent host.
Leão CA; Ferreira-Paim K; Andrade-Silva L; Mora DJ; da Silva PR; Machado AS; Neves PF; Pena GS; Teixeira LS; Silva-Vergara ML
Med Mycol; 2011 May; 49(4):352-5. PubMed ID: 21028946
[TBL] [Abstract][Full Text] [Related]
32. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Pesti M; Papp T; Vágvölgyi C
FEMS Microbiol Lett; 2010 Jun; 307(2):175-84. PubMed ID: 20636975
[TBL] [Abstract][Full Text] [Related]
33. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
[TBL] [Abstract][Full Text] [Related]
34. Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil.
Costa AK; Sidrim JJ; Cordeiro RA; Brilhante RS; Monteiro AJ; Rocha MF
Mycopathologia; 2010 Mar; 169(3):207-13. PubMed ID: 19847668
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients.
Sun HY; Singh N
Clin Infect Dis; 2009 Mar; 48(6):745-55. PubMed ID: 19193110
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis.
Galgóczy L; Papp T; Kovács L; Ordögh L; Vágvölgyi C
Med Mycol; 2009 May; 47(3):331-5. PubMed ID: 18798117
[TBL] [Abstract][Full Text] [Related]
37. Statins for infection and sepsis: a systematic review of the clinical evidence.
Falagas ME; Makris GC; Matthaiou DK; Rafailidis PI
J Antimicrob Chemother; 2008 Apr; 61(4):774-85. PubMed ID: 18263570
[TBL] [Abstract][Full Text] [Related]
38. Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil.
Almeida AM; Matsumoto MT; Baeza LC; de Oliveira E Silva RB; Kleiner AA; Melhem Mde S; Mendes Giannini MJ;
FEMS Yeast Res; 2007 Jan; 7(1):152-64. PubMed ID: 17311593
[TBL] [Abstract][Full Text] [Related]
39. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
Souza LK; Fernandes Ode F; Kobayashi CC; Passos XS; Costa CR; Lemos JA; Souza-Júnior AH; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
